Core News Facts
PepsiCo, AT&T, and Pfizer are highlighted as blue-chip dividend stocks with notable yield advantages over the S&P 500. PepsiCo offers a current yield of 4.2%, AT&T 4.5%, and Pfizer 6.7%, with all three companies providing stable income despite recent market volatility.
PepsiCo reported over $90 billion in revenue and more than $8 billion in earnings for the past three years, marking its 54th consecutive year of dividend increases. AT&T is projected to generate $18 billion in free cash flow this year, significantly exceeding its $8.2 billion annual dividend payout. Pfizer, while facing challenges with a payout ratio exceeding 100%, is investing in growth despite potential patent cliffs impacting revenue.
Currently, PepsiCo trades at a forward price-to-earnings (P/E) ratio of 16, AT&T at 11, and Pfizer at just under 9, signifying their respective valuations may be favorable compared to average S&P 500 stocks, which trade at a forward P/E of 22.
5 Stocks Our Experts Predict Could Double In the Next Year
By submitting your email, you'll also get a free pivot & flow membership. A free daily market overview. You can unsubscribe at any time.
